Medicare has delayed a program for older Americans that would've required participating insurance companies to cover GLP-1 weight loss drugs such as Novo Nordisk's Wegovy and Eli Lilly's Zepbound.

Patches marketed as ‘GLP-1 patches’ actually do not contain GLP-1 active ingredients, such as semaglutide or tirzepatide. Currently, no ‘GLP-1 patches’ are approved by the Food and Drug Administration ...

If you watched the Super Bowl in 2026, you likely saw Serena Williams share her weight loss journey on GLP-1 medications in a commercial. Like millions of others around the country, if you’ve ever ...

Amazon One Medical launched a GLP-1 program integrating obesity care with Amazon Pharmacy. Pricing for the popular weight loss drugs will begin at as low as $25 per month with insurance. Shares of ...

Amazon is rolling out a new GLP‑1 program aimed at simplifying access to popular weight-loss drugs, from doctor visits to prescription delivery. The company announced on April 21 that Amazon One ...

Have a question for Jessica Rendall or our other editors? Ask here for a chance to be featured in a story. Thank you for submitting your question. Keep reading Forbes Advisor for the chance to see the ...

Some people’s genes influence how much weight they will lose and what side effects they will experience while taking GLP-1 drugs, such as Ozempic and Zepbound. “The results that we got made perfect ...

Amazon.com AMZN0.56%increase; green up pointing triangle is launching a program that provides access to GLP-1 treatments through its One Medical primary care arm. The company said Tuesday the new ...

Share on Pinterest Combo treatment may work best for those who don’t respond to GLP-1s alone, a recent review suggests. Image credit: Lajst/Getty Images Over the past few years, GLP-1 receptor ...

The most common side effects of GLP-1 medications like Ozempic and Wegovy are gastrointestinal (GI) issues, including nausea, vomiting, and diarrhea. Those side effects may persist during treatment.

Interactive assistance via eHealth for small- and medium-sized enterprises’ employer and health care manager teams on tobacco control (eSMART-TC): A cluster ...

More than 1 in 8 American adults are using GLP-1’s for weight loss. Experts say these are the nutritional gaps and side effects that should not to be overlooked. As GLP-1 medications continue to ...